Dietary Supplements and Exercise in Aging Adults

NCT ID: NCT00761553

Last Updated: 2013-01-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-10-31

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the effects of food supplements and strength training on appetite, the amount of energy used, and body composition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Exercise

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Solid dietary supplements with exercise

Group Type EXPERIMENTAL

Dietary supplements with exercise

Intervention Type OTHER

Resistive exercise along with consuming two dietary supplements every day during both 8 week intervention periods, for a total of 16 weeks.

2

Solid dietary supplements without exercise

Group Type EXPERIMENTAL

Dietary supplement without exercise

Intervention Type DIETARY_SUPPLEMENT

Consuming two dietary supplements every day during both 8 week intervention periods, for a total of 16 weeks.

3

Liquid dietary supplements with exercise

Group Type EXPERIMENTAL

Dietary supplements with exercise

Intervention Type OTHER

Resistive exercise along with consuming two dietary supplements every day during both 8 week intervention periods, for a total of 16 weeks.

4

Liquid supplements without exercise

Group Type EXPERIMENTAL

Dietary supplement without exercise

Intervention Type DIETARY_SUPPLEMENT

Consuming two dietary supplements every day during both 8 week intervention periods, for a total of 16 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary supplements with exercise

Resistive exercise along with consuming two dietary supplements every day during both 8 week intervention periods, for a total of 16 weeks.

Intervention Type OTHER

Dietary supplement without exercise

Consuming two dietary supplements every day during both 8 week intervention periods, for a total of 16 weeks.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults age 55 and older
* Body mass index 20 to ≤35 kg/m2
* Weight stable (\<4kg change within the last 3 months)
* Constant habitual activity patterns (no deviation \> 1x/wk of 30 min/session within last 3 months)
* Clinically normal blood and urine profiles as determined by our study physician
* Not taking medications known to influence appetite nor any anti-inflammatory steroid medications
* No hip replacements

Exclusion Criteria

* Adults with medical conditions that might place them at risk for participating in the study or interfere with the successful completion of the study protocol will be excluded
Minimum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Purdue University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wayne Campbell

Wayne Campbell, Ph.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Purdue University

West Lafayette, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIH/NIA 5R01AG021911

Identifier Type: -

Identifier Source: secondary_id

0509003026

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.